会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Synthesis of cycloalkyldiarylphosphines
    • 环烷基二芳基膦的合成
    • US5654486A
    • 1997-08-05
    • US620824
    • 1996-03-25
    • K. Pushpananda A. SenaratneArcelio J. MalcolmFelix M. OrihuelaHassan Y. Elnagar
    • K. Pushpananda A. SenaratneArcelio J. MalcolmFelix M. OrihuelaHassan Y. Elnagar
    • C07F9/50
    • C07F9/5077
    • Partially sterically-hindered cycloalkyl chlorides are reacted with lithium diarylphosphides in inert liquid hydrocarbon reaction media to form cycloalkyldiarylphosphines. Aryl lithium is coproduced. The process makes it possible to avoid, or at least substantially eliminate, the interaction with or cleavage of cyclic ether reaction media such as tetrahydrofuran, previously the solvent of choice for conducting this type of reaction. Also during the conduct of the present process the chloro-substituted cycloalkane does not undergo any appreciable reaction with the coproduced aryl lithium as it is formed. Thus improvements both in yield and quality of the cycloalkyldiarylphosphine product are made possible. A comprehensive three-step process for converting triarylphosphine to cycloalkyldiarylphosphine is also described.
    • 部分空间位阻环烷基氯与惰性液体烃反应介质中的二芳基磷化锂反应形成环状二芳基膦。 共生产芳基锂。 该方法使得可以避免或至少基本上消除环醚反应介质如四氢呋喃的相互作用或切割,其中先前是用于进行这种反应的溶剂。 此外,在本方法的进行过程中,氯取代的环烷烃在形成时不与共同生产的芳基锂发生任何明显的反应。 因此,可以改善环烷基二芳基膦产物的产率和质量。 还描述了将三芳基膦转化为环烷基二芳基膦的综合三步法。
    • 3. 发明授权
    • Synthesis of cycloalkyldiarylphosphines
    • 环烷基二芳基膦的合成
    • US5654485A
    • 1997-08-05
    • US620823
    • 1996-03-25
    • K. Pushpananda A. SenaratneArcelio J. MalcolmFelix M. OrihuelaHassan Y. Elnagar
    • K. Pushpananda A. SenaratneArcelio J. MalcolmFelix M. OrihuelaHassan Y. Elnagar
    • C07F9/50
    • C07F9/5077
    • By reacting certain partially sterically-hindered chloro-substituted cycloalkanes with sodium and/or potassium diarylphosphides in an ether reaction medium, not only are useful cycloalkyldiarylphosphines produced, but in addition the chloro-substituted cycloalkane does not undergo any appreciable reaction with the coproduced aryl sodium and/or aryl potassium as it is formed. Moreover, the process makes it possible to avoid or at least to greatly reduce interaction with or cleavage of cyclic ether reaction media such as tetrahydrofuran. Thus the process makes possible improvements both in yield and quality of the cycloalkyldiarylphosphite product. A two-stage process conducted in an ether reaction medium is also described. In the first stage the sodium and/or potassium diarylphosphine reactant is produced by reaction between sodium and/or potassium and triarylphosphine.
    • 通过使某些部分空间位阻的氯取代的环烷烃与醚反应介质中的二芳基磷酸钠和/或钾反应,不仅产生了有用的环烷基二芳基膦,而且氯取代的环烷烃与共同生产的芳基钠不会发生明显的反应 和/或芳基钾。 此外,该方法可以避免或至少大大降低与环醚反应介质如四氢呋喃的相互作用或裂解。 因此,该方法可以改善环烷基二芳基亚磷酸酯产物的产率和质量。 还描述了在醚反应介质中进行的两阶段方法。 在第一阶段,二钠和/或二芳基膦反应物是通过钠和/或钾与三芳基膦之间的反应产生的。
    • 8. 发明授权
    • Synthesis of beta-thymidine
    • β-胸苷的合成
    • US4914233A
    • 1990-04-03
    • US162508
    • 1988-03-01
    • John N. FreskosK. Pushpananda A. Senaratne
    • John N. FreskosK. Pushpananda A. Senaratne
    • C07H19/06
    • C07H19/06
    • A process is provided in which a mixture of alpha- and beta-anomers is converted selectively to the desired beta-thymidine. The process involves the following steps: (a) converting a mixture of alpha- and beta-anomers of tetra-O-acylribofuranose to tri-O-acyl-.beta.-ribothymidine; (b) converting tri-O-acyl-.beta.-ribothymidine to .beta.-ribothymidine; (c) converting .beta.-ribothymidine to 2,2'-anhydro-.beta.-thymidine; (d) converting 2,2'-anhydro-.beta.-thymidine to 2'-halo-2'-deoxy-5-methyluridine; and (e) converting 2'-halo-2'-deoxy-5-methyluridine to beta-thymidine. The mixture of alpha- and beta-anomers of tetra-O-acylribofuranose may be produced by any suitable procedure such as by converting lower alkyl ribofuranoside to the tetra-O-acylribofuranose mixture. The lower alkyl ribofuranosides may in turn be produced by various methods. However, a desirable way of effecting this conversion involves use of D-ribose as the starting material which is converted to the lower alkyl ribofuranoside.
    • 提供了一种方法,其中将α-和β-端基异构体的混合物选择性转化成所需的β-胸苷。 该方法包括以下步骤:(a)将四-O-酰基呋喃核糖的α-和β-端基异构体的混合物转化为三-O-酰基-β-核糖胸苷; (b)将三-O-酰基-β-核糖胸苷转化为β-二硫胸苷; (c)将β-二硫胸苷转化为2,2'-脱水-β-胸苷; (d)将2,2'-脱水-β-胸苷转化为2'-卤代-2'-脱氧-5-甲基尿苷; 和(e)将2'-卤代-2'-脱氧-5-甲基尿苷转化为β-胸苷。 四-O-酰基呋喃核糖的α-和β-端基异构体的混合物可以通过任何合适的方法制备,例如通过将低级烷基呋喃核糖苷转化成四-O-酰基呋喃核糖混合物。 可以通过各种方法制备低级烷基呋喃核糖。 然而,实现该转化的期望方式涉及使用D-核糖作为转化为低级烷基核糖呋喃糖苷的起始原料。